Pfizer Inc
NYSE: PFE
$26.21
+$0.38 (+1.5%)
Closing Price on November 29, 2024
PFE Articles
According to Reuters, RIM (RIMM) posted strong earnings and added it 10 millionth subscriber. Reuters writes that Wal-Mart (WMT) is already getting ready for holiday price wars by beginning to drop...
Published:
According to Reuters, RIM (RIMM) posted strong earnings and added it 10 millionth subscriber. Reuters writes that Wal-Mart (WMT) is already getting ready for holiday price wars by beginning to drop...
Published:
GE (GE) has been hoping that growth in the developing world would begin to offset slower sales in places like the US and Europe. It may be that they are finally getting their wish. The company told...
Published:
The Nigerian government is suing Pfizer (PFE) claiming that it "deceived patients and caused the death of 11 children in 1996 when it performed clinical trials for a new drug." According to the...
Published:
According to Reuters, UBS (UBS) will write-off $3.4 billion, another victim of the credit crunch. Reuters writes that the Teamsters and UPS (UPS) have come to a new contract. Reuters writes that...
Published:
A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug. Oddly, Pfizer’s shares were down 1.2% to $24.35. The Big Pharma...
Published:
Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic form are more likely to have a heart attack or die....
Published:
According to Reuters, Bush will outline a plan to help holders of sub-prime mortgages. Reuters writes that Dell (DELL) topped Wall St. estimates but sees costs drops slowing. Reuters writees that...
Published:
A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases....
Published:
Biopharmaceutical company Xoma (XOMA) is having its luck day. After its stock traded down as low as $2.24, its shares are up almost 20% today on news that it bacterial cell expression technology to...
Published:
According to Reuters, Bear Stearns (BSC) has several potential buyers including JP Morgan (JPM) and Bank of America (BAC) Reuters writes that a court overturned a patent infringement award won by...
Published:
Pfizer (PFE) has FDA approval for a new drug that "blocks the CCR5 co-receptor that serves as a main doorway for the HIV virus into immune cells." It will be marketed as Selzentry and is the first...
Published:
Below are key short interest statistics for July. The figures are as of July 13 compared to June 15, 2007 Largest Short Positions Company ...
Published:
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock...
Published:
Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48% to $1.3 billion. The loss of U.S. exclusivity for Zoloft and Norvasc hurt earnings as did...
Published: